Intellectual Property Cases filed in Delaware
Cases 91 - 100 of 209
Biogen International GmbH et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00829
Plaintiff: Biogen International GmbH and Biogen MA Inc.
Defendant: Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Orexo AB et al v. Actavis Elizabeth LLC et al
as 1:2017cv00758
Plaintiff: Orexo AB and Orexo US, Inc.
Defendant: Actavis Elizabeth LLC , Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. et al
as 1:2017cv00449
Plaintiff: Onyx Therapeutics, Inc.
Defendant: Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd
Counter_claimant: Teva Pharmaceuticals USA, Inc.
Counter_defendant: Onyx Therapeutics, Inc.
Cause Of Action: 35 U.S.C. § 271
Ferring Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00435
Plaintiff: Ferring Pharmaceuticals Inc. and Ferring International Center S.A.
Defendant: Teva Pharmaceuticals USA, Inc.
Counter_claimant: Teva Pharmaceuticals USA, Inc.
Counter_defendant: Ferring International Center S.A. and Ferring Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00410
Plaintiff: Bristol-Myers Squibb Company and Pfizer Inc.
Defendant: Teva Pharmaceuticals USA, Inc.
Counter_claimant: Teva Pharmaceuticals USA, Inc.
Counter_defendant: Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00393
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Glaxo Group Ltd. v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00357
Plaintiff: Glaxo Group Ltd.
Defendant: Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Salix Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00329
Plaintiff: Salix Pharmaceuticals, Inc. and Dr. Falk Pharma GmbH
Defendant: Teva Pharmaceuticals USA, Inc.
Counter_claimant: Teva Pharmaceuticals USA, Inc.
Counter_defendant: Dr. Falk Pharma GmbH and Salix Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
BioDelivery Sciences International, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2017cv00282
Plaintiff: BioDelivery Sciences International, Inc. and Arius Two, Inc.
Defendant: Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv00249
Plaintiff: Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant: Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?